Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Market Perform to Outperform. Analyst Price Forecast Suggests 42.56% ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research note issued to investors on Monday, February 3rd. Leerink ...

PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its participation in the 2025 Leerink Partn ...

Investment analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Owens & Minor in a report issued on Monday, February 3rd. Leerink Partnrs analyst M. Cherny now ...

Leerink Partners adjusted their financial outlook on Cencora Inc (NYSE: COR), increasing the price target to $301 from the previous $287 while keeping an Outperform rating on the stock. The revision ...

The New Shares were issued in relation to the sales agreement between the Company and Leerink Partners LLC (”Leerink Partners”) entered into on May 8, 2024, with respect to an at-the-market ...

The New Shares were issued in relation to the sales agreement between the Company and Leerink Partners LLC (”Leerink Partners”) entered into on May 8, 2024, with respect to an at-the-market (“ATM”) ...

Analyst Michael Cherny of Leerink Partners maintained a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price target of $11.50. Leverage the power of TipRanks ...

The dividend suspension is "prudent and somewhat overdue," said Leerink Partners analyst Michael Cherny. "We see this as the right move for Walgreens' ability to reboot the business but the near ...

Analyst Whit Mayo from Leerink Partners reiterated a Buy rating on Acadia Healthcare (ACHC – Research Report) and keeping the price target at $48.00. Leverage the power of TipRanks' Smart Score ...

The shares were related to a sales agreement with Leerink Partners LLC, allowing for an at-the-market offering program with a potential aggregate value of up to $100 million, though the newly ...